Patient
SITE009-0120
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2026-01-23
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-06-25
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-19 (study day 140); relationship: RELATED
moderate
assessed
2026-03-04
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-08-28 (study day 27); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.